Collegeville, PA, United States of America

Patrick M Eidam

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Stevenage, GB (2020)
  • Collegeville, PA (US) (2017 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovator Behind Heterocyclic Amides: Patrick M. Eidam

Introduction

Patrick M. Eidam, a prominent inventor based in Collegeville, Pennsylvania, has made significant contributions to the field of biotechnology and pharmaceuticals through his innovative work. With a total of eight patents to his name, Eidam is recognized for his expertise in developing compounds that can lead to breakthroughs in kinase inhibition, an important area in cancer research and drug development.

Latest Patents

Among his latest patents is a noteworthy invention titled "Heterocyclic Amides as Kinase Inhibitors." This patent discloses a range of compounds formulated to act as effective kinase inhibitors, potentially paving the way for new therapeutic strategies in treating various diseases. His work in this area not only reflects his commitment to advancing medical science but also highlights the significance of targeted treatments in modern healthcare.

Career Highlights

Patrick Eidam has built a successful career at GlaxoSmithKline Intellectual Property Development Limited, where his work focuses on innovative drug development. His efforts encompass extensive research and application of patent law to protect his groundbreaking inventions and enhance the company’s portfolio. His role has enabled him to contribute to projects that push the boundaries of what is possible in the pharmaceutical industry.

Collaborations

Throughout his career, Eidam has collaborated with respected colleagues such as Deepak Bandyopadhyay and Philip Anthony Harris. These partnerships not only enhance the scope of his research but also foster an environment of shared knowledge and innovation. Working alongside talented professionals allows for a diverse exchange of ideas, driving advancements in their collective research efforts.

Conclusion

In conclusion, Patrick M. Eidam stands out as an accomplished inventor whose work in the field of kinase inhibitors is poised to impact the pharmaceutical landscape significantly. With a total of eight patents and a commitment to innovation at GlaxoSmithKline, he continues to push the boundaries of science. His collaborations with fellow researchers further solidify the importance of teamwork in driving progress and fostering future breakthroughs in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…